ALS Limited (CPBLF) Stock: Price, Forecast & Analyst Target
ALS Limited (CPBLF) — price $15.50 (0.00%), as of the Oct 2, 2026 trading session; market cap $7.87B.
Educational signal · not a buy or sell recommendation · How to read this
ALS Limited · CPBLF
ALS Limited is a global provider of professional technical services, specializing in testing, measurement, and inspection across Life Sciences, Commodities, and Industrial sectors. Headquartered in Australia, the company serves diverse markets from environmental analysis to mining and infrastructure projects worldwide.
Price as of Oct 2, 2026
Key Statistics
MoonshotScore is not published for this security.
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $15.50 |
| Change on the day | 0.00% |
| Market capitalisation | $7.87B |
| Price / earnings (trailing) | 33.27 |
| Shares traded on the day | 161 |
Price & events
Other perspectives
Council score for ALS (CPBLF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
6 lenses, 6 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Oct 4, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the CPBLF film — every key number, told as a short cinematic story
~2 min · open the film
What is ALS (CPBLF), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. ALS Limited (CPBLF) is the company analyzed here. It employs 23,342 people. In Q4 FY2026 it reported revenue of $1.16B and net income of $123M. The market values it at $7.87B.
What do the latest results show for ALS (CPBLF)?
Short answer · as of
The most recent reported quarter, Q4 FY2026, carried revenue of $1.16B. Against analyst estimates the company has EPS beat 6 of 8 reports.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 FY2026 | $1.16B | $123M | $0.24 (diluted) |
| Q2 FY2026 | $1.16B | $99M | $0.20 (diluted) |
| Q4 FY2025 | $1.07B | $90M | $0.18 (diluted) |
| Q2 FY2025 | $1.02B | $88M | $0.18 (diluted) |
What are the financial strengths and risks for ALS (CPBLF)?
Short answer
The distress and quality screens read Altman Z 5.53 · Piotroski F 7. Trailing ratios: ROE 18.9% · ROA 8.0% · current ratio 1.47 · earnings yield 2.8% · free-cash-flow yield 2.0%.
What should you watch next at ALS (CPBLF)?
Short answer · as of
Current published price targets run low $28.00 · high $28.00 · consensus $28.00 · median $28.00 against a quoted price of $15.50 (as of Oct 2, 2026).
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The next earnings date is not yet scheduled in the calendar we read.
- No insider Form 4 transaction falls inside the window this page reads.
Checked against the records this page reads, on the dates shown above.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $28.00 – $28.00
- Consensus target
- $28.00
- Median target
- $28.00
Consensus record · Captured .
Measured against a quoted price of $15.50 (as of Oct 2, 2026).
What Investors Ask About ALS (CPBLF)
These answers are editorial: 1 of these 8 answers is drawn from the CPBLF research dossier (written Jun 14, 2026 by gemini-2.5-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
Is CPBLF a good stock to buy?
Stock Expert AI does not rate CPBLF buy, sell or hold. ALS Limited has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the CPBLF stock price today?
The last price recorded on this page for ALS Limited (CPBLF) is $15.50, as of the Oct 2, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the CPBLF price target?
The analyst consensus price target for ALS Limited (CPBLF) is $28.00 (range $28.00 to $28.00, median $28.00), per FMP data captured Oct 4, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
What does ALS Limited do?
ALS Limited provides professional technical services globally, specializing in testing, measurement, and inspection. Its operations are divided into three segments: Life Sciences, Commodities, and Industrial.
What are the key factors to evaluate for CPBLF?
Evaluate CPBLF on fundamentals, analyst consensus, and risk factors. P/E: 33.27x. Analysts target $28.00 (+81%). **Expansion in Life Sciences Environmental Testing:** The global demand for environmental analytical testing is projected to grow significantly, driven by increasing regulatory scrutiny, public awareness of climate change, and industrial pollution concerns. Not financial advice.
How frequently does CPBLF data refresh on this page?
CPBLF's price is the last quote we recorded, from the Oct 2, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven CPBLF's recent stock price performance?
ALS Limited (CPBLF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Global presence across Africa, Asia/Pacific, Europe, Middle East, North Africa, and the Americas. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CPBLF overvalued or undervalued right now?
ALS Limited (CPBLF) trades at 33.27x earnings. Analysts target $28.00 (+81%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (17 figures)
The 17 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 14 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $15.50 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-04T14:44:30.922Z. | |
px.change | Change on the day | 0.00% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $7.87B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-02. FMP quote timestamp: 2026-10-02T20:00:00.000Z. Captured from FMP at 2026-10-04T14:44:30.014Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | $0.00 | FMP | Financial Modeling Prep (FMP) · quote | |
px.pe | Price / earnings (trailing) | 33.27 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 161 | FMP | Financial Modeling Prep (FMP) · quote | |
id.employees | Employees | 23,342 | FMP | Financial Modeling Prep (FMP) · company profile — Captured 2026-10-04 | |
fin.q_revenue | Revenue, Q4 FY2026 | $1.16B | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_income | Net income, Q4 FY2026 | $123M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_table | Quarterly income statement | 4 quarters through Q4 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
earn.pt | Stored analyst price targets | low $28.00 · high $28.00 · consensus $28.00 · median $28.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
earn.pt_range | Analyst price target, low to high | $28.00 – $28.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
earn.pt_consensus | Consensus analyst price target | $28.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied | |
earn.pt_median | Median analyst price target | $28.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 4, 2026 · Coverage not supplied |
UNRECORDED — 3 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.history | Reported versus estimated, recent quarters | EPS beat 6 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-01 · Expired observation | |
fin.scores | Distress and quality screens | Altman Z 5.53 · Piotroski F 7 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-03 · Expired observation | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 18.9% · ROA 8.0% · current ratio 1.47 · earnings yield 2.8% · free-cash-flow yield 2.0% | — | UNRECORDED | Stored key metrics — Date unknown |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.